UnknownNot Applicable

Follow-up Study of Complications of Acute Pancreatitis

China1,300 participantsStarted 2014-11

Plain-language summary

This is a follow-up study focusing on long-term complications of acute pancreatitis. The primary purposes include: 1. To assess the incidence of type 2 diabetes mellitus（2-DM）,impaired glucose tolerance, metabolic abnormalities of blood lipids after acute pancreatitis. 2. To observe the possible long-term clinical outcomes after acute pancreatitis attack, which may include: chronic pancreatitis, pancreatic cancer, pancreatogenic portal hypertension, autoimmune pancreatitis et al. 3. To evaluate the long-term influence of acute lung injury(PaO2/FiO2\<200,FiO2 means fraction of inspiration O2) in AP patients during ICU stay on life qualities of the patients; 4. To observe the prognosis of the local complications of acute pancreatitis(AP) patients; it might be helpful to find the most effective and targeted interventions aiming at different phases after AP attack.

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Clinical diagnosis of acute pancreatitis from our hospital * Must be signed the informed consent Exclusion Criteria: * Failed to complete the questionnaire survey and the follow-up examination

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

change in glucose

Timeframe: An expected duration which estimated to be average of 4.2 years

Change in C-Peptide

Timeframe: An expected duration which estimated to be average of 4.2 years

Change in blood liquid

Timeframe: An expected duration which estimated to be average of 4.2 years

Change in the Levels of fecal elastase-1

Timeframe: An expected duration which estimated to be average of 4.2 years

Trial details

NCT IDNCT02305914

SponsorThe First Affiliated Hospital of Nanchang University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2016-01

Contact for this trial

Hongrong Xu, MD

15870649026 xuhr2009@163.com

View on ClinicalTrials.gov More Pancreatitis trials

Plain-language summary

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

change in glucose

Timeframe: An expected duration which estimated to be average of 4.2 years

Change in C-Peptide

Timeframe: An expected duration which estimated to be average of 4.2 years

Change in blood liquid

Timeframe: An expected duration which estimated to be average of 4.2 years

Change in the Levels of fecal elastase-1

Timeframe: An expected duration which estimated to be average of 4.2 years